全文获取类型
收费全文 | 113415篇 |
免费 | 9681篇 |
国内免费 | 3819篇 |
专业分类
耳鼻咽喉 | 1010篇 |
儿科学 | 2276篇 |
妇产科学 | 1332篇 |
基础医学 | 19656篇 |
口腔科学 | 1693篇 |
临床医学 | 7857篇 |
内科学 | 17287篇 |
皮肤病学 | 2415篇 |
神经病学 | 8534篇 |
特种医学 | 1744篇 |
外国民族医学 | 29篇 |
外科学 | 9988篇 |
综合类 | 12692篇 |
现状与发展 | 19篇 |
预防医学 | 6829篇 |
眼科学 | 1595篇 |
药学 | 18646篇 |
10篇 | |
中国医学 | 5210篇 |
肿瘤学 | 8093篇 |
出版年
2023年 | 1811篇 |
2022年 | 2250篇 |
2021年 | 3843篇 |
2020年 | 3615篇 |
2019年 | 4532篇 |
2018年 | 4549篇 |
2017年 | 4149篇 |
2016年 | 3776篇 |
2015年 | 4306篇 |
2014年 | 6503篇 |
2013年 | 7726篇 |
2012年 | 6603篇 |
2011年 | 7959篇 |
2010年 | 6518篇 |
2009年 | 5890篇 |
2008年 | 5517篇 |
2007年 | 5194篇 |
2006年 | 4519篇 |
2005年 | 3751篇 |
2004年 | 3483篇 |
2003年 | 3050篇 |
2002年 | 2395篇 |
2001年 | 1943篇 |
2000年 | 1666篇 |
1999年 | 1469篇 |
1998年 | 1178篇 |
1997年 | 1151篇 |
1996年 | 981篇 |
1995年 | 1071篇 |
1994年 | 915篇 |
1993年 | 828篇 |
1992年 | 714篇 |
1991年 | 670篇 |
1990年 | 596篇 |
1989年 | 495篇 |
1988年 | 433篇 |
1987年 | 367篇 |
1986年 | 372篇 |
1985年 | 1134篇 |
1984年 | 1417篇 |
1983年 | 1053篇 |
1982年 | 1199篇 |
1981年 | 1099篇 |
1980年 | 846篇 |
1979年 | 760篇 |
1978年 | 547篇 |
1977年 | 454篇 |
1976年 | 520篇 |
1975年 | 384篇 |
1973年 | 240篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
11.
Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient and clinician alike. Since the discovery of each virus, extensive knowledge regarding epidemiology, virologic properties, and the natural clinical and immunologic history of acute and chronic infections has been generated. Basic discoveries about host immunologic responses to acute and chronic viral infections, combined with virologic data, has led to vaccines to prevent Hepatitis A, B, and E and highly efficacious antivirals for Hepatitis B and C. These therapeutic breakthroughs are transforming the fields of hepatology, transplant medicine in general, and public and global health. Most notably, there is even an ambitious global effort to eliminate chronic viral hepatitis within the next decade. While attainable, there are many barriers to this goal that are being actively investigated in basic and clinical labs on the local, national, and international scales. Herein, we discuss pertinent clinical information and recent organizational guidelines for each of the individual hepatitis viruses while also synthesizing this information with the latest research to focus on exciting future directions for each virus. 相似文献
12.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
13.
14.
15.
16.
17.
《International journal of medical microbiology : IJMM》2022,312(1):151544
Mycobacterium tuberculosis (M. tuberculosis) encodes an essential enzyme acetyl ornithine aminotransferase ArgD (Rv1655) of arginine biosynthetic pathway which plays crucial role in M. tuberculosis growth and survival. ArgD catalyzes the reversible conversion of N-acetylornithine and 2 oxoglutarate into glutamate-5-semialdehyde and L-glutamate. It also possesses succinyl diaminopimelate aminotransferase activity and can thus carry out the corresponding step in lysine biosynthesis. These essential roles played by ArgD in amino acid biosynthetic pathways highlight it as an important metabolic chokepoint thus an important drug target. We showed that M. tuberculosis ArgD rescues the growth of ΔargD E. coli grown in minimal media validating its functional importance. Phylogenetic analysis of M. tuberculosis ArgD showed homology with proteins in gram positive bacteria, pathogenic and non-pathogenic mycobacteria suggesting the essentiality of this protein. ArgD is a secretory protein that could be utilized by M. tuberculosis to modulate host innate immunity as its moonlighting function. In-silico analysis predicted it to be a highly antigenic protein. The recombinant ArgD protein when exposed to macrophage cells induced enhanced production of pro-inflammatory cytokines TNF, IL6 and IL12 in a dose dependent manner. ArgD also induced the increased production of innate immune effector molecule NOS2 and NO in macrophages. We also demonstrated ArgD mediated activation of the canonical NFkB pathway. Notably, we also show that ArgD is a specific TLR4 agonist involved in the activation of pro-inflammatory signaling for sustained production of effector cytokines. Intriguingly, ArgD protein treatment activated macrophages to acquire the M1 phenotype through the increased surface expression of MHCII and costimulatory molecules CD80 and CD86. ArgD induced robust B-cell response in immunized mice, validating its antigenicity potential as predicted by the in-silico analysis. These properties of M. tuberculosis ArgD signify its functional plasticity that could be exploited as a possible drug target to combat tuberculosis. 相似文献
18.
《Injury》2023,54(7):110767
AimThis network meta-analysis aims to compare functional outcomes and complications between conservative treatment and surgery for distal radius fractures in patients aged 60 years and over.MethodsWe searched the PubMed, EMBASE, and Web of Science databases for randomized controlled trials (RCTs) assessing the effect of conservative treatment and surgery for distal radius fractures in patients aged 60 years and over. Primary outcomes included grip strength and overall complications. Secondary outcomes included Disabilities of the Arm, Shoulder, and Hand (DASH) scores, Patient-Rated Wrist Evaluation (PRWE) scores, wrist range of motion and forearm rotation, and radiographic assessment. All continuous outcomes were assessed using standardized mean differences (SMDs) with 95% confidence intervals (CIs), and binary outcomes were assessed using odds ratio (OR) with 95% CIs. The surface under the cumulative ranking curve (SUCRA) was used to determine a hierarchy of treatments. Cluster analysis was performed for grouping treatments based on the SUCRA values of primary outcomes.ResultsFourteen RCTs were included to compare conservative treatment, volar lockedplate (VLP), K-wires fixation, and external-fixation. VLP outperformed conservative treatment for 1-year and minimum 2-year grip strength (SMD; 0.28 [0.07 to 0.48] and 0.27 [0.02 to 0.53], respectively). VLP yielded the optimal grip strength at 1-year and minimum 2-year follow-up (SUCRA; 89.8% and 86.7%, respectively). In a subgroup analysis of patients aged 60 to 80 years old, VLP outperformed conservative treatment in DASH and PRWE scores (SMD, 0.33 [0.10, 0.56] and 0.23 [0.01, 0.45], respectively). In addition, VLP had the fewest complications (SUCRA = 84.3%). Cluster analysis suggested that VLP and K-wire fixation were more effective treatment groups.ConclusionEvidence to date demonstrates that VLP provides measurable benefits in grip strength and fewer complications to those 60 years of age and over, and that benefit is not reflected in current practice guidelines. There is a subgroup of patients where K-wire fixation outcomes are similar to those of VLP; defining this subgroup may yield substantial societal benefits. 相似文献
19.
胶质淋巴系统是一个主要由星形胶质细胞水通道蛋白4介导的依靠动脉、静脉周围血管间隙的脑脊液-脑组织液交换流动的系统,是阿尔茨海默病、脑卒中、帕金森病、失眠、抑郁症等脑病的共同特征,是一条新的脑代谢途径,可以清除包括β-淀粉样蛋白、乳酸在内的代谢产物。本文综合分析了全球有关胶质淋巴系统在脑部疾病的研究,得出:胶质淋巴系统可能为神经退行性疾病等发病机制和诊治策略研究带来新视角;胶质淋巴系统有望为一些脑部疾病诊断提供新的有效证据;胶质淋巴系统可能是脑部疾病治疗给药方式的新途径。 相似文献